Lead the Peptide Revolution
As the only industry-driven summit focused on uniting key decision-makers including Chief Executive Officers, Chief Development Officers, Chief Scientific Officers, as well as VPs and Directors of CMC, Peptide Drug Product Development, Pharmaceutical Chemistry Development, Peptide Drug Delivery and more, from pioneering peptide drug companies such as Novo Nordisk, Eli Lilly, Carocell Bio and Xeris Pharma to name just a few; this meeting is a must-attend.
Our partners joined us to build impactful connections with experts who are pioneering state-of-the-art peptide formulation and delivery approaches to innovate in peptide drug product differentiation and accelerate speed to market with your assistance.Â
Collaborate with us to create a bespoke partnership package that aligns with your preferences as:Â
CDMOs and peptide synthesiser providers to make peptides as both active pharmaceutical ingredients, and as drug delivery vehicles at both the R&D stage and subsequent scale-up of manufacturing
Pre-clinical model suppliers offering animal models, in vivo testing, toxicology studies and regulatory support for novel or reformulated peptide drugsÂ
Excipient, ingredient and raw material providers, offering formulation expertise, analytical testing, compatibility and stability testing to optimize peptide drug product constitution without compromising on efficacyÂ
Device development and testing providers offering device design and prototyping, formulation compatibility testing and device manufacturing scale-up capabilitiesÂ
Through our bespoke partnership package, you can:
Who Attended in 2025?
